# Safety and Pharmacokinetics of Fluzoparib in Healthy Subjects and Those With Impaired Kidney Function

> **NCT05032235** · PHASE1 · COMPLETED · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 24 (actual)

## Conditions studied

- Renal Impairment

## Interventions

- **DRUG:** Fluzoparib
- **DRUG:** Fluzoparib
- **DRUG:** Fluzoparib

## Key facts

- **NCT ID:** NCT05032235
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-09
- **Primary completion:** 2023-12-04
- **Final completion:** 2023-12-05
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2024-01-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05032235

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05032235, "Safety and Pharmacokinetics of Fluzoparib in Healthy Subjects and Those With Impaired Kidney Function". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05032235. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*